Drug Shortage Report for PMS-QUINAPRIL
Report ID | 172827 |
Drug Identification Number | 02340550 |
Brand name | PMS-QUINAPRIL |
Common or Proper name | QUINAPRIL |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | QUINAPRIL |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-11-25 |
Estimated end date | 2023-05-26 |
Actual end date | 2023-05-16 |
Shortage status | Resolved |
Updated date | 2023-05-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-10-28 | French | Compare |
v1 | 2022-10-28 | English | Compare |